GENE ONLINE|News &
Opinion
Blog

Feature
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
The US FDA has extended the approval of Evkeeza (evinacumab-dgnb) to treat children aged 5 to 11 with homozygous familial hypercholesterolemia (HoFH), an inherited condition …

Home Read More »

2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Special
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
To cut costs going into the second quarter of this year, prescription digital therapeutics company Better Therapeutics announced that it plans to lay off 35% …

35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway Read More »

2023-03-27
Ways to Reduce Carbon Emission in Cement Manufacturing
Concrete is the most widely used artificial material on earth, majorly comprising of Portland cement along with other materials such as fly ash, sand, slag cement and gravel. 

Approximately 30 billion metric tons of concrete is used each year globally in the infrastructure space to build dams, buildings, sewage systems, etc. As the world population is set to touch the eight billion mark, the demand for concrete and cement is expected to skyrocket too. Since the production of cement production releases a significant amount of CO2 into the atmosphere, it is a contributor to global warming.

Cement production accounts for nearly eight percent of global carbon emissions.Over the past years, CO2 concentration has increased from 300 ppm to 410 ppm (parts per million), an alarming situation that earth has never experienced before. 

2023-03-26
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
Born and raised in Japan, Takashi “Tora” Toraishi has a master’s degree and a Ph.D. from the University of Tokyo, in nuclear chemistry. Before he …

Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi Read More »

2023-03-23
LATEST
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
2023-03-28
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC
2023-03-28
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab)
2023-03-27
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Deals
In-Home Kidney Disease Management Company, Monogram, Raises $375 Million
2023-01-13
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Soon-To-Be J&J Spinoff, Kenvue Files for $100 Million IPO
2023-01-06
Alkermes to Break Oncology Sector into Independent Company
2022-11-03
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
BioTouch Buys Ireland’s Titan Solutions To Expand International Outreach
2023-03-03
Kinnate Buys Back $24 Million Worth Of Shares From China Venture Kinnjiu
2023-02-22
Ranking & Reports
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
Patent Landscape Analysis of Gene Therapy
2023-02-08
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Categories
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Industrializing iPSC and Harnessing its Medical Applications – An Interview with Dr. Hong-Lin Su
2023-03-06
Transforming Southern California Biotech Landscape: An Interview With SoCalBio CEO Ahmed Enany
2022-10-18
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Astellas Clears Primary Endpoints In Prostate Cancer And Menopause Trials
2023-03-14
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
Kinnate Buys Back $24 Million Worth Of Shares From China Venture Kinnjiu
2023-02-22
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Biodegradable Skin Staple! KMU Earned Major Recognition in the Annual Main Event of Plastic Surgery
2023-02-09
In-Home Kidney Disease Management Company, Monogram, Raises $375 Million
2023-01-13
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
Government Agencies Spring into Action After Biomanufacturing Executive Order
2022-09-14
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
First-Ever Insect Brain Neuron Map Completed
2023-03-21
The World’s First mRNA Vaccine to Fight Against Antibiotic-Resistant Bacteria
2023-03-14
Fifth HIV Patient Cured After Stem Cell Transplant in Germany
2023-03-01
Biodegradable Skin Staple! KMU Earned Major Recognition in the Annual Main Event of Plastic Surgery
2023-02-09
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Using Sound Waves to Sort Blood-Based Nanoparticles
2022-12-07
Scroll to Top